Unmasking Genetic Vulnerabilities in Breast Cancer Through SNP Analysis
Authors
Jiayi Zhu
![](/api/crop/media/uploads/journals/journal/EJT_4-5.jpg?geometry=280x368)
Share
Annotation
Breast cancer is a prevalent and severe malignancy with significant morbidity and mortality rates worldwide. This investigation sought to elucidate the relationship between single nucleotide polymorphisms (SNPs) and breast cancer. Genome-wide sequencing data from the Sequence Read Archive were harnessed, and comprehensive pipelines were developed to align sequences against chromosome 10 in a cohort of individuals with a history of breast cancer. The study found that while the PTEN gene exhibited just a single unique SNP, suggesting its genetic resilience, other genes presented with a notably higher number of SNPs. Specifically, genes without a defined function harbored the most significant number of unique SNPs. Prior research has underscored its role as a tumor suppressor and its critical association with various malignancies, including breast cancer. These insights offer a deeper understanding of the genomic intricacies of breast cancer, revealing potential genetic vulnerabilities and emphasizing the significance of particular genes and SNP contributions to the disease.
Keywords
Authors
Jiayi Zhu
![](/api/crop/media/uploads/journals/journal/EJT_4-5.jpg?geometry=280x368)
Share
References:
Andrews, S. (2010). FastQC: a quality control tool for high throughput sequence data.
Bolger, A. M., Lohse, M., & Usadel, B. (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics, 30(15), 2114-2120.
Breast cancer risk factors you can’t change. (n.d.). Retrieved from https://www.cancer.org/cancer/types/breast-cancer/risk-and-prevention/breast-ca ncer-risk-factors-you-cannot-change.html#:~:text=BRCA1%20and%20BRCA2%3 A%20The%20most,proteins%20that%20repair%20damaged%20DNA.
Breast cancer stages. (2019b, September 17). Retrieved from https://www.breastcancer.org/pathology-report/breast-cancer-stages
Breast cancer treatment. (2021, August 1). Retrieved from https://pubmed.ncbi.nlm.nih.gov/34383430/
Centers for Disease Control and Prevention. (n.d.). Basic Information About Breast Cancer. Retrieved from https://www.cdc.gov/cancer/breast/basic_info/index.htm#:~:text=Each%20year% 20in%20the%20United,breast%20cancer%20than%20White%20women.
Chow, J. T., & Salmena, L. (2020). Recent advances in PTEN signalling axes in cancer. Faculty reviews, 9, 31. https://doi.org/10.12703/r/9-31
Coughlin S. S. (2019). Social determinants of breast cancer risk, stage, and survival. Breast cancer research and treatment, 177(3), 537–548. https://doi.org/10.1007/s10549-019-05340-7
Cunningham, F., et al. (2021). Ensembl 2021. Nucleic Acids Research, 49(D1), D884-D891.
Fagny, M., Platig, J., Kuijjer, M. L., Lin, X., & Quackenbush, J. (2020). Nongenic cancer-risk SNPs affect oncogenes, tumour-suppressor genes, and immune function. British journal of cancer, 122(4), 569–577. https://doi.org/10.1038/s41416-019-0614-3
Fisusi, F. A., & Akala, E. O. (2019). Drug Combinations in Breast Cancer Therapy. Pharmaceutical nanotechnology, 7(1), 3–23. https://doi.org/10.2174/2211738507666190122111224
Giammarile, F., Vidal-Sicart, S., Paez, D., Pellet, O., Enrique, E. L., Mikhail-Lette, M., Morozova, O., Maria Camila, N. M., Diana Ivonne, R. S., Delgado Bolton, R. C., Valdés Olmos, R. A., & Mariani, G. (2022). Sentinel Lymph Node Methods in Breast Cancer. Seminars in nuclear medicine, 52(5), 551–560. https://doi.org/10.1053/j.semnuclmed.2022.01.006
He, Y., Liu, H., Chen, Q., Shao, Y., & Luo, S. (2019). Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism. Molecular genetics & genomic medicine, 7(9), e871. https://doi.org/10.1002/mgg3.871
Howe, R. B., Miron-Shatz, T., Hanoch, Y., Omer, Z. B., O’Donoghue, C., & Ozanne, E. M. (2014). Personalized Medicine through SNP Testing for breast cancer risk: Clinical implementation. Journal of Genetic Counseling, 24(5), 744–751. https://doi.org/10.1007/s10897-014-9803-7
Kerr, A. J., Dodwell, D., McGale, P., Holt, F., Duane, F., Mannu, G., Darby, S. C., & Taylor, C. W. (2022). Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality. Cancer treatment reviews, 105, 102375. https://doi.org/10.1016/j.ctrv.2022.102375
Langmead, B., & Salzberg, S. (2012). Fast gapped-read alignment with Bowtie 2. Nature Methods, 9(4), 357-359.
Li, H., et al. (2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics, 25(16), 2078-2079.
NCBI (2021). SRA Toolkit. National Center for Biotechnology Information.
Roberts, E., Howell, S., & Evans, D. G. (2023). Polygenic risk scores and breast cancer risk prediction. Breast (Edinburgh, Scotland), 67, 71–77. https://doi.org/10.1016/j.breast.2023.01.003
Rossi, L., Mazzara, C., & Pagani, O. (2019). Diagnosis and Treatment of Breast Cancer in Young Women. Current treatment options in oncology, 20(12), 86. https://doi.org/10.1007/s11864-019-0685-7
Su, Y., Yao, Q., Xu, Y., Yu, C., Zhang, J., Wang, Q., Li, J., Shi, D., Yu, B., Zeng, Y., Zhu, X., Bai, Q., & Zhou, X. (2021). Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in genetics, 12, 674094. https://doi.org/10.3389/fgene.2021.674094
Trayes, K. P., & Cokenakes, S. E. H. (2021). Breast Cancer Treatment. American family physician, 104(2), 171–178.
Van Veen, E. M., Brentnall, A. R., Byers, H., Harkness, E. F., Astley, S. M., Sampson, S., . . . Evans, D. G. (2018). Use of Single-Nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction. JAMA Oncology, 4(4), 476. https://doi.org/10.1001/jamaoncol.2017.4881
Wilkinson, L., & Gathani, T. (2022). Understanding breast cancer as a global health concern. The British journal of radiology, 95(1130), 20211033. https://doi.org/10.1259/bjr.20211033
World Health Organization. (n.d.). Breast Cancer: Key Facts. Retrieved from https://www.who.int/news-room/fact-sheets/detail/breast-cancer#:~:text=Key%20f acts,every%20country%20in%20the%20world.
Yehia, L., Keel, E., & Eng, C. (2020). The Clinical Spectrum of PTEN Mutations.
Annual review of medicine, 71, 103–116. https://doi.org/10.1146/annurev-med-052218-125823
Zhang, H., Feng, L., Zhou, J., Song, S., & Jiang, Z. (2013). PTEN mutation, methylation and expression in breast cancer patients. Oncology Letters, 6(1), 161–168. https://doi.org/10.3892/ol.2013.1331